Tracking Larry Robbins’ Glenview Capital Management Portfolio – Q3 2023 Update

• Glenview Capital Management’s 13F portfolio value remained at ~$4.4B this quarter. 
• They increased Fiserv (FI) and Amazon.com (AMZN) while reducing Cigna (CI) and Global Payments (GPN). 
• The top three stakes are Cigna (CI), SPDR S&P 500 Index ETF (SPY) Puts, and Tenet Healthcare (THC). They add up to ~33% of the portfolio. 

This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 11/14/2023. Please visit our Tracking Larry Robbins’ Glenview Capital Management Portfolio article for an idea on his investment philosophy and our previous update for the fund’s moves during Q2 2023.

 

This quarter, Robbins’ 13F portfolio value remained almost steady at ~$4.4B. There are 30 positions that are significantly large. The spreadsheet below lists those larger positions individually. The top five stakes are Cigna (CI), SPDR S&P 500 Index ETF (SPY) Puts, Tenet Healthcare (THC), United Health Services (UHS), and Global Payments (GPN). Together they are at ~43% of the 13F assets.

 

 

The spreadsheet below highlights changes to Robbins’ 13F stock holdings in Q3 2023:

 

 

 

Source: John Vincent. Data constructed from Glenview Capital Management’s 13F filings for Q2 2023 and Q3 2023.